Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sideroblastic anemias].

T Matthes1

  • 1Hämatologie, Departement Innere Medizin, Universitätsspital Genf. thomas.matthes@hcuge.ch

Therapeutische Umschau. Revue Therapeutique
|February 3, 2006
PubMed
Summary
This summary is machine-generated.

Sideroblastic anemias involve sideroblasts in bone marrow. Most cases are acquired myelodysplastic syndromes, with largely unknown genetic causes for acquired forms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

Nature communications·2024
Same author

Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study.

Leukemia·2016
Same author

Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow.

Leukemia·2015
Same author

Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.

Leukemia·2015
Same author

Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations.

Swiss medical weekly·2010
Same author

In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development.

Histology and histopathology·2009
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Area of Science:

  • Hematology
  • Mitochondrial Biology
  • Genetics

Context:

  • Sideroblastic anemias are a diverse group of blood disorders.
  • They are characterized by ring sideroblasts in bone marrow aspirates.
  • Classification distinguishes heme synthesis defects from mitochondrial pathway issues (primary mtDNA or secondary nuclear DNA defects).

Purpose:

  • To review the classification and understanding of sideroblastic anemias.
  • To highlight the distinction between hereditary and acquired forms.
  • To discuss current treatment approaches and knowledge gaps.

Summary:

  • Sideroblastic anemias present with sideroblasts in bone marrow.
  • While hereditary forms have known molecular defects, acquired forms, often myelodysplastic syndromes, have largely unknown genetic underpinnings.

Related Experiment Videos

  • Treatment primarily involves supportive care, with bone marrow transplantation being rare.

    • Impact:

    • This review clarifies the complex nature of sideroblastic anemias.
    • It emphasizes the need for further research into the genetic basis of acquired forms.
    • Improved understanding may lead to targeted therapies for these conditions.